Loading company…
Totus Medicines uses drug discovery technology to develop therapies for complex diseases.
Founded in 2019 and based in Emeryville, Totus Medicines uses a drug discovery platform and covalent molecules to identify candidates for difficult-to-treat targets, including in cancer, heart disease, and neurodegeneration. In December 2022, it raised USD 66.00 mn in Series B funding led by Data Collective, with Camford Capital and Northpond Ventures participating.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in